Anti-retroviral Drugs Market to hit USD 42.5 billion by 2032, says Global Market Insights Inc.
Anti-retroviral drugs industry is projected to witness a CAGR of 4.2% during the period 2024-2032. This growth can be ...
GlobalData on MSN14 天
Gilead’s lenacapavir: HIV prospects strongest in long-acting combos with Merck’s islatravir
Gilead Sciences’ capsid inhibitor lenacapavir has the most competitive potential in long-acting combination regimens in HIV, ...
News Medical on MSN14 天
Cardiovascular risks of COVID-19 antivirals
Study reviews cardiovascular side effects linked to antiviral therapies for COVID-19, highlighting the need for careful ...
pulmonologyadvisor9 天
FDA Alert: Pulmonology Drug Approvals and Recalls, Medical Device Updates
FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...
Taiwan News25 天
Phosphoramidite Market Valued at $1.08 Billion in 2023, Projected to Grow at 7.37% CAGR ...
Global Phosphoramidite Market is valued approximately USD 1.08 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.37% over the forecast period 2024-2032. Read the ...
Verywell Health on MSN1 年
Horsetail for Inflammation, Hair, and Bone Health: Does It Work?
It's also thought to help relieve fluid retention (edema), stop bleeding, and heal wounds. However, horsetail’s safety and ...
The Citizen1 天
Polokwane hosts Lipa on first-line HIV treatment
Lipa and Dr. Mathe presents latest HIV treatment guidelines, highlighting benefits of rilpivirine in first-line therapy.
The EMBO Journal17 天
Glutaminolysis provides nucleotides and amino acids to regulate osteoclast differentiation ...
Metabolic rewiring is essential for osteoclast differentiation and bone resorption. This study shows that glutaminolysis ...
Hand, Foot, And Mouth Disease Treatment Market To Reach US$ 5,175.1 Million By 2032 At A ...
Hand, Foot, And Mouth Disease Treatment Market To Reach US$ 5,175.1 Million By 2032 At A CAGR Of 6.1% Astute Analytica ...